[go: up one dir, main page]

AU2002210761A1 - Method of determining susceptibility to diseases - Google Patents

Method of determining susceptibility to diseases

Info

Publication number
AU2002210761A1
AU2002210761A1 AU2002210761A AU1076102A AU2002210761A1 AU 2002210761 A1 AU2002210761 A1 AU 2002210761A1 AU 2002210761 A AU2002210761 A AU 2002210761A AU 1076102 A AU1076102 A AU 1076102A AU 2002210761 A1 AU2002210761 A1 AU 2002210761A1
Authority
AU
Australia
Prior art keywords
diseases
determining susceptibility
susceptibility
determining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002210761A
Inventor
Simon Jeremy Dowell
Michael John Sheehan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0026945A external-priority patent/GB0026945D0/en
Priority claimed from GB0029577A external-priority patent/GB0029577D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2002210761A1 publication Critical patent/AU2002210761A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Physics & Mathematics (AREA)
  • Neurosurgery (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002210761A 2000-11-03 2001-11-02 Method of determining susceptibility to diseases Abandoned AU2002210761A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0026945A GB0026945D0 (en) 2000-11-03 2000-11-03 Therapy
GB0026945.6 2000-11-03
GB0029577.4 2000-12-02
GB0029577A GB0029577D0 (en) 2000-12-02 2000-12-02 Therapy
PCT/GB2001/004865 WO2002036816A2 (en) 2000-11-03 2001-11-02 Method of determining susceptibility to diseases

Publications (1)

Publication Number Publication Date
AU2002210761A1 true AU2002210761A1 (en) 2002-05-15

Family

ID=26245235

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002210761A Abandoned AU2002210761A1 (en) 2000-11-03 2001-11-02 Method of determining susceptibility to diseases

Country Status (2)

Country Link
AU (1) AU2002210761A1 (en)
WO (1) WO2002036816A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20060272A1 (en) 2004-05-24 2006-05-22 Glaxo Group Ltd (2R, 3R, 4S, 5R, 2'R, 3'R, 4'S, 5'S) -2.2 '- {TRANS-1,4-CYCLOHEXANODIYLBIS- [IMINO (2 - {[2- (1-METHYL- 1H-IMIDAZOL-4-IL) ETHYL] AMINO} -9H-PURIN-6,9-DIYL)]} BIS [5- (2-ETHYL-2H-TETRAZOLE-5-IL) TETRAHYDRO-3,4-FURANODIOL] AS AN A2A AGONIST
SE0402832D0 (en) * 2004-11-18 2004-11-18 Astrazeneca Ab Methods
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
WO2002036816A3 (en) 2003-05-30
WO2002036816A2 (en) 2002-05-10

Similar Documents

Publication Publication Date Title
IL153824A0 (en) Method and kit for diagnosis of diseases
AU2002243231A1 (en) Method of treating autoimmune diseases
AU2002220920A1 (en) Method for identification of genes involved in specific diseases
AU2001234608A1 (en) Methods for analysis of gene expression
AU2002332430A1 (en) Methods of treating neuropilin-mediated diseases
AU2002228991A1 (en) Methods for treating diseases caused by deficiencies of alpha-l-iduronidase
SG94782A1 (en) Method for production of acrylic acid
AU2002214286A1 (en) Method of profiling protein
AU2001267428A1 (en) Direct detection of individual molecules
AU2001277815A1 (en) Method to determine the quality of eye-optics
AU2001294258A1 (en) Method of purifying plavastatin
AU2002330624A1 (en) Method of determining susceptibility to inflammatory bowel disease
AU2001280436A1 (en) Process to increase protein stability
AU2002301109A1 (en) Method for the prediction of preeclampsia and other diseases
GB2360646B (en) Method of displaying full-charge-state
AU2002210761A1 (en) Method of determining susceptibility to diseases
AU2002246926A1 (en) 12-hydroxy-eicosatrienoic acid analogs and methods of use thereof
NO20031927L (en) Improved process for preparation of gabapentin intermediate
AU2001273392A1 (en) Method of detecting an increased susceptibility to breast cancer
AU2001258659A1 (en) Improved methods of transfection
AU2001292468A1 (en) Methods and means of rna analysis
AU2001232571A1 (en) Method relating to manufacturing of steel
AU2002237238A1 (en) Identification of modulators of dham-kinase and inflammatory diseases
GB0100151D0 (en) Methods of sputtering
AU2001233246A1 (en) Novel use of ribozymes to block gene expression